|
Market Closed -
OTC Markets
22:59:59 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.1601 USD | -3.26% |
|
-5.21% | -30.01% |
Evolution of the Average Target: Northwest Biotherapeutics, Inc.
Evolution of the Target Price: Northwest Biotherapeutics, Inc.
Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.
ecf225d0f4402bdaefb4a03c5ab5e._JNMdv_-f606Li9bwC2ghDbYM7Fgnb3EbIO8iqdQ5xU.mqEoEIa0EsFCYlsh9wDL51KHduZS1durCq7528QViyGdzBxHhY0qlFR4RA~20f365ce9243e36f136b8c735df85338
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +524.61% | |||
| +16.92% | |||||
| +17.91% | |||||
| +15.47% | |||||
| +66.29% | |||||
| +23.62% | |||||
| +8.57% | |||||
| +18.41% | |||||
| -8.01% | |||||
| +62.99% | |||||
| Average | +74.68% | |||||
| Weighted average by Cap. | +23.33% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1601USD
Average target price
1.000USD
Spread / Average Target
+524.61%
High Price Target
1.000USD
Spread / Highest target
+524.61%
Low Price Target
1.000USD
Spread / Lowest Target
+524.61%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- NWBO Stock
- Consensus Northwest Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
